Travere Therapeutics
(NASDAQ) TVTX
Travere Therapeutics Financials at a Glance
Market Cap
$4.39B
Revenue (TTM)
$536.20M
Net Income (TTM)
-$21.42M
EPS (TTM)
-$0.53
P/E Ratio
-88.22
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$47.16
Volume
43,966
Open
$47.90
Price
$47.16
Volume
43,966
Open
$47.90
Previous Close
$47.16
Daily Range
$46.54 - $48.57
52-Week Range
$13.88 - $48.61
Dividend
$0.00
Beta (Volatility)
1.23 (Average)
Price
$47.16
Volume
43,966
Open
$47.90
Previous Close
$47.16
Daily Range
$46.54 - $48.57
52-Week Range
$13.88 - $48.61
TVTX News
TVTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Travere Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
497
CEO
Eric M. Dube, PhD
Website
www.travere.comHeadquarters
San Diego, CA 92130, US
TVTX Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
-11%
Net Income Margin
-4%
Return on Equity
-69%
Return on Capital
-13%
Return on Assets
-4%
Earnings Yield
-1.13%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.39B
Shares Outstanding
92.99M
Volume
43.97K
Avg. Volume
2.15M
Financials (TTM)
Gross Profit
$480.39M
Operating Income
-$62.82M
EBITDA
$22.22M
Operating Cash Flow
$37.78M
Capital Expenditure
$0.00
Free Cash Flow
$37.78M
Cash & ST Invst.
$322.80M
Total Debt
$328.73M
Travere Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$127.20M
+55.6%
Gross Profit
$100.43M
+30.3%
Gross Margin
78.96%
N/A
Market Cap
$4.39B
N/A
Market Cap/Employee
$11.40M
N/A
Employees
385
N/A
Net Income
-$37.10M
+10.0%
EBITDA
-$11.70M
+54.2%
Quarterly Fundamentals
Net Cash
-$62.99M
+19.5%
Accounts Receivable
$87.30M
+153.9%
Inventory
$6.36M
+61.6%
Long Term Debt
$321.65M
-1.4%
Short Term Debt
$6.02M
-91.9%
Return on Assets
-3.86%
N/A
Return on Invested Capital
-13.28%
N/A
Free Cash Flow
-$62.54M
-15.9%
Operating Cash Flow
-$40.37M
+4.3%